Edit
GKC
http://www.globalkineticscorporation.com.au/Last activity: 22.12.2023
Active - Reference to Home
Global Kinetics Corporation (GKC) was established in 2007 to commercialise innovative technology developed by Professor Malcolm Horne, from the Florey Institute of Neuroscience & Mental Health (the largest Neuroscience research team in Australia and the Southern Hemisphere), and Dr Rob Griffiths, for the precise recording, quantification and reporting of movement symptoms of neurological disease.
Consisting of an interactive watch that collects movement data, proprietary algorithms and a detailed report, the PKG™ system also correlates the frequency and severity of symptoms with respect to consumption of Parkinson’s medication.
The lead product, the Parkinson’s KinetiGraph™ movement recording is a unique and useful tool for neurologists in the management of Parkinson’s disease.
Consisting of an interactive watch that collects movement data, proprietary algorithms and a detailed report, the PKG™ system also correlates the frequency and severity of symptoms with respect to consumption of Parkinson’s medication.
The lead product, the Parkinson’s KinetiGraph™ movement recording is a unique and useful tool for neurologists in the management of Parkinson’s disease.
Employees: 11-50
Total raised: $1.5M
Investors 2
| Date | Name | Website |
| - | Bioscience... | bioscience... |
| - | Brandon Ca... | brandoncap... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 19.05.2015 | - | $1.5M | - |
Mentions in press and media 10
| Date | Title | Description |
| 22.12.2023 | Global Kinetics Corporation raises $1.5 million in equity crowdfunding to fuel US expansion | article-article-body Australian health tech company Global Kinetics Corporation has raised $1.5 million on equity crowdfunding platform OurCrowd to kick-start its US expansion. The capital injection is the largest equity funding round in Au... |
| 15.05.2018 | Wearables build momentum for Parkinson’s disease research | The types of data collected will include movement and different types of physiologic and environmental information nearly all day, every day, according to a description of the study. Verily and PPMI will make raw and curated data available ... |
| 10.04.2018 | FDA-cleared wearable for Parkinson’s disease patients gets $6M+ funding boost | The wearable, styled as a smartwatch, generates a score for bradykinesia — a slowness of movement associated with Parkinson’s disease, dyskinesia — involuntary muscle movements, and tremor. The smartwatch is worn for seven days before it is... |
| 16.06.2015 | Health tech start-up GKC raises $14.8 million with $1.5 million of it secured via OurCrowd | - |
| 19.05.2015 | Global Kinetics Corporation raises $1.5 million in equity crowdfunding to fuel US expansion | Australian health tech company Global Kinetics Corporation has raised $1.5 million on equity crowdfunding platform OurCrowd to kick-start its US expansion. The capital injection is the largest equity funding round in Australia to date, and ... |
| 13.10.2014 | GKC raises $368.2m for legal-focused credit ops fund | Private equity firm Gerchen Keller Capital has registered $368.2m worth of commitments for what appears to be its debut |
| 10.09.2014 | Press Release: Global Kinetics Corporation announces FDA clearance of the Personal KinetiGraph for assessment of Parkinson’s Disease symptoms | MELBOURNE, Australia — Global Kinetics Corporation, a leading mobile health technologies company, today announced that the U.S. Food and Drug Administration (FDA) has cleared the marketing of the company’s Personal KinetiGraph™ (PKG™) techn... |
| 30.05.2012 | Victorian start-up secures $3.5 million for breakthrough Parkinson’s technology | A Victoria-based company plans to commercialise breakthrough technology for patients with Parkinson’s disease, after securing $3.5 million in equity funding and government grants. Global Kinetics Corporation was established in 2007 to comme... |
| - | FDA-cleared wearable for Parkinson’s disease patients gets $6M+ funding boost | Global Kinetics Corp., an Australian device developer with an FDA-cleared wearable designed to make objective assessments of Parkinson’s disease patients’ movement, has received more than $6 million (AUS $7.75 million) from the Australian g... |
| - | Wearables build momentum for Parkinson’s disease research | Verily Study Watch In a collaboration with the Michael J Fox Foundation, Verily will provide its Verily Study Watches to more than 800 U.S. participants in the MJFF-led Parkinson’s Progression Markers Initiative (PPMI). The goal is to give ... |